PharmalucencePharmalucence

  • ABOUT US
    • Leadership
  • NUCLEAR MEDICINE PRODUCTS
    • Sulfur Colloid
      • Patient Information
      • Healthcare Professionals
    • Mertiatide
    • Sestamibi
    • Mebrofenin
    • Pyrophosphate
    • Medronate
    • Vial Shields
  • MANUFACTURING STANDARDS
  • FACILITY
  • NEWS
  • CONTACT

FDA Approval Received for Use of Sulfur Colloid

16
Aug
Date August 16, 2012
Categories Company Updates, Press Releases

FDA Approval Received for Use of Sulfur Colloid

Pharmalucence receives FDA approval for use of Sulfur Colloid Injection (SCI) to locate lymph nodes in malignant melanoma patients.

Sulfur Colloid Melanoma Press Release Aug 2012Download
Author Sailesh Piplani

Categories

  • Company Updates 25
  • Press Releases 16
  • Uncategorized 3

Recent Posts

  • Please visit our “Virtual Booth” at the upcoming virtual SNMMI meeting, June 11-15, 2021June 18, 2020
  • Kit for the Preparation of Technetium Tc99m Mertiatide – now available.June 18, 2020
  • Pharmalucence today becomes Sun RadiopharmaApril 1, 2020
  • Come See UsNovember 5, 2019
  • Come See UsNovember 1, 2019

Archives

  • June 2020
  • April 2020
  • November 2019
  • April 2019
  • September 2017
  • February 2017
  • April 2016
  • March 2015
  • July 2014
  • May 2014
  • April 2014
  • December 2012
  • November 2012
  • September 2012
  • August 2012
  • May 2012
  • February 2012
  • January 2012
  • December 2011
  • July 2011
  • March 2011
  • June 2010
  • July 2009
  • August 2008
  • January 2008
  • COMPANY
  • NUCLEAR MEDICINE PRODUCTS
  • MANUFACTURING STANDARDS
  • FACILITY
  • NEWS
  • CONTACT

USEFUL LINKS

  • HOME
  • RESOURCES
  • CAREERS
  • LEGAL STATEMENT
  • PRIVACY POLICY
29 Dunham Road, Billerica, MA 01821 | Telephone: 781-275-7120 © Sun Pharmaceutical Industries Inc. All rights reserved.